Zui Tan
Impact in
- Hepatology top 10%
- Liver physiology and pathology
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Glycosylation and Glycoproteins Research 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Co-authors
- Tinghong Ye (10 shared papers)Hongyao Liu (10 shared papers)Cailing Gan (10 shared papers)Yuting Xie (7 shared papers)Taixiong Xue (5 shared papers)Yuqin Yao (6 shared papers)Hongbao Sun (1 shared paper)Di Wang (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (3 papers)Liver International (1 paper)Phytotherapy Research (1 paper)Journal of Neuroscience (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zui Tan
23 papers receiving 528 citations
Zui Tan's Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 109
- Pulmonary and Respiratory Medicine 123
- Cancer Research 55
- Epidemiology 125
- Pharmacology 29
Countries citing papers authored by Zui Tan
This map shows the geographic impact of Zui Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zui Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zui Tan more than expected).
Fields of papers citing papers by Zui Tan
This network shows the impact of papers produced by Zui Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zui Tan. The network helps show where Zui Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Zui Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy Hit paper breakdown → | 2021 | 153 |
| 2 | 2021 | 73 | |
| 3 | 2012 | 37 | |
| 4 | 2016 | 35 | |
| 5 | 2020 | 31 | |
| 6 | 2022 | 27 | |
| 7 | 2009 | 24 | |
| 8 | 2022 | 23 | |
| 9 | 2007 | 22 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 16 | |
| 12 | 2007 | 16 | |
| 13 | 2014 | 14 | |
| 14 | 2022 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 7 | |
| 17 | Therapeutic effects of Erbin inhibitor on spinal cord contusion in mice. | 2019 | 4 |
| 18 | 2013 | 3 | |
| 19 | Construction of adeno-associated virus coexpression system for human angiopoietin-1 and VEGF gene. | 2004 | 3 |
| 20 | 2025 | 2 |
About Zui Tan
Zui Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cellular and Molecular Neuroscience and Ecology, having authored 23 papers that have together received 531 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Angiogenesis and VEGF in Cancer (4 papers), Bacteriophages and microbial interactions (3 papers), Liver physiology and pathology (3 papers), Glycosylation and Glycoproteins Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Nerve injury and regeneration (2 papers). The work is most often cited by research in Hepatology (109 citations), Pulmonary and Respiratory Medicine (123 citations), Cancer Research (55 citations), Epidemiology (125 citations) and Pharmacology (29 citations). Zui Tan has collaborated with scholars based in China and United States. Frequent co-authors include Tinghong Ye, Hongyao Liu, Cailing Gan, Yuting Xie, Taixiong Xue, Yuqin Yao, Hongbao Sun, Di Wang, Xingyu Qiu and Chuan Liang. Their work appears in journals such as European Journal of Medicinal Chemistry, Liver International, Phytotherapy Research, Journal of Neuroscience and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.